Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin (HA) that are limited in their ability to protect against different strains of influenza. Cytotoxic T lymphocytes recognizing the conserved internal nucleoprotein (NP) and matrix protein (M1) are capa...

Podrobná bibliografie
Hlavní autoři:	Mullarkey, C, Boyd, A, van Laarhoven, A, Lefevre, E, Veronica Carr, B, Baratelli, M, Molesti, E, Temperton, N, Butter, C, Charleston, B, Lambe, T, Gilbert, S
Médium:	Journal article
Jazyk:	English
Vydáno:	2013

Podobné jednotky

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
Autor: Antrobus, R, a další
Vydáno: (2014)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
Autor: Antrobus, R, a další
Vydáno: (2014)

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.
Autor: Lillie, P, a další
Vydáno: (2012)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine
Autor: Powell, T, a další
Vydáno: (2013)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
Autor: Timothy J Powell, a další
Vydáno: (2013-01-01)

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Autor: Berthoud, T, a další
Vydáno: (2011)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
Autor: Antrobus, R, a další
Vydáno: (2012)

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.
Autor: Lambe, T, a další
Vydáno: (2013)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
Autor: Richard D Antrobus, a další
Vydáno: (2012-01-01)

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies
Autor: Cécile Janssen, a další
Vydáno: (2022-11-01)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
Autor: Martin C. Langenmayer, a další
Vydáno: (2023-06-01)

Adenoviral vectors as novel vaccines for influenza.
Autor: Coughlan, L, a další
Vydáno: (2015)

Novel MVA-based vaccine expressing influenza NP and M1 activates cross-reactive T cell responses in human nasopharynx-associated lymphoid tissue (NALT) (conference abstract)
Autor: Puksuriwong, S, a další
Vydáno: (2018)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
Autor: Lambe, T, a další
Vydáno: (2012)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine
Autor: Lambe, T, a další
Vydáno: (2012)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
Autor: Ota, M, a další
Vydáno: (2011)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
Autor: Ota, M, a další
Vydáno: (2011)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
Autor: Tully, C, a další
Vydáno: (2017)

Development of NP-Based Universal Vaccine for Influenza A Viruses
Autor: Ekramy E. Sayedahmed, a další
Vydáno: (2024-02-01)

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol
Autor: Swayze, H, a další
Vydáno: (2019)

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responsesResearch in context
Autor: David Pattinson, a další
Vydáno: (2024-05-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Autor: Pedro M. Folegatti, a další
Vydáno: (2019-03-01)

Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report
Autor: Anwar A. Sayed
Vydáno: (2023-05-01)

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial
Autor: Allison R. Thompson, a další
Vydáno: (2019-02-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
Autor: Folegatti, P, a další
Vydáno: (2019)

Clinical advances in viral-vectored influenza vaccines
Autor: Sebastian, S, a další
Vydáno: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
Autor: Saranya Sridhar, a další
Vydáno: (2015-04-01)

Clinical Advances in Viral-Vectored Influenza Vaccines
Autor: Sarah Sebastian, a další
Vydáno: (2018-05-01)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
Autor: Wei Dong, a další
Vydáno: (2018-10-01)

Safety of routine childhood vaccine coadministration versus separate vaccination
Autor: Bauwens, J, a další
Vydáno: (2022)

Safety of routine childhood vaccine coadministration versus separate vaccination
Autor: Simon de Lusignan, a další
Vydáno: (2022-09-01)

Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine
Autor: I. V. Krasilnikov, a další
Vydáno: (2022-07-01)

Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
Autor: Hua Shi, a další
Vydáno: (2024-12-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
Autor: Arunkumar, G, a další
Vydáno: (2019)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
Autor: McMahon, M, a další
Vydáno: (2019)

Influenza and influenza vaccination in children
Autor: Viorel ALEXANDRESCU, a další
Vydáno: (2017-09-01)

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Autor: Irene González-Domínguez, a další
Vydáno: (2024-11-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
Autor: Kaori Sano, a další
Vydáno: (2018-08-01)

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Autor: Teresa Hauguel, a další
Vydáno: (2024-10-01)

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
Autor: Boyd, A, a další
Vydáno: (2013)